Risk of secondary progressive multiple sclerosis: A longitudinal study

Risk of secondary progressive multiple sclerosis increases with age, duration of illness and worsening disability and decreases with improving disability. Therapy may delay the onset of secondary p...

Treatment for Secondary Progressive MS - WebMD

Your treatment plan may change once your disease switches from relapsing-remitting multiple sclerosis (RRMS) to secondary progressive multiple sclerosis (SPMS). Find out what to expect based on the...

Treatments For Non-Active Secondary Progressive Multiple Sclerosis Remain Scarce

tackle Multiple Sclerosis (MS) through immunosuppression and a reduction of patient... non-active secondary progressive MS patients in an open-label expanded access (EA) program. The...

Progressive multiple sclerosis: from pathogenic mechanisms to treatment

along with possible new therapeutic approaches. Keywords: axonal loss; multiple sclerosis; neurodegeneration; primary progressive multiple sclerosis; secondary progressive multiple sclerosis.

Secondary Progressive Multiple Sclerosis - Tiziana Life Sciences

Secondary progressive multiple sclerosis: current knowledge and future challenges

The secondary progressive phase of multiple sclerosis (MS), which is characterised by a steady accrual of fixed disability after an initial relapsing remitting course, is not clearly understood. Al...

Multiple Sclerosis (MS) | Johns Hopkins Medicine

Overview ; Multiple sclerosis (MS) is a long-lasting (chronic) disease of the central nervous system. It is thought to be an autoimmune disorder, a condition in which the body attacks itself by mistake. MS is an unpredictable disease that affects people differently. Some people with MS may have only mild symptoms. Others may lose their ability to see clearly, write, speak, or walk when communication between the brain and other parts of the body becomes disrupted. Myelin is a protein and fatty su...

Interferon beta for secondary progressive multiple sclerosis

Objectives: The main objective was to verify whether IFNs treatment in Secondary Progressive Multiple Sclerosis (SPMS) is more effective than placebo in reducing the number of patients who...

A focus on secondary progressive multiple sclerosis (SPMS): challenges in diagnosis and definition

Secondary progressive multiple sclerosis (SPMS) is the second most common form of multiple sclerosis (MS). One in two relapse remitting multiple sclerosis (RRMS) patients will develop SPMS within 1...

Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple scleros....

Abstract Background: Secondary progressive multiple sclerosis, for which no satisfactory treatment presently exists, accounts for most of the disability in patients with multiple sclerosis....